South Africa’s Competition Tribunal has reportedly approved of the Nestle-Pfizer Nutrition baby formula merger, but with hard-hitting conditions, according to reports. Nestle and Pfizer stand as the largest and third-largest infant formula market in the country. The approval’s catch, however, requires a large divestment from Pfizer of its infant milk formula business, as the Tribunal found that the merger would leave only Aspen as a top competitor in the market. The Tribunal has included a list of concessions the parties need to address before the merger goes through. According to reports, remedies that have been suggested are similar to the remedies used to approve of the same deal in Australia; under the terms, Pfizer would reportedly divest its infant milk formula business in South Africa, and its new owner would rebrand the company and its products.
Full Content: BDLive
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI